For: | Lahad A, Weiss B. Current therapy of pediatric Crohn’s disease. World J Gastrointest Pathophysiol 2015; 6(2): 33-42 [PMID: 25977836 DOI: 10.4291/wjgp.v6.i2.33] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v6/i2/33.htm |
Number | Citing Articles |
1 |
David A. Hill, William A. Faubion. Pediatric Inflammatory Bowel Disease. 2017; : 15 doi: 10.1007/978-3-319-49215-5_2
|
2 |
Olga Bellou, Dimosthenis Chrysikos, Ourania Schoinohoriti, Ioannis Alexandrou, Efstratios Christianakis. Perianal Skin Tags Revealing Asymptomatic Crohn’s Disease in a 12-Year-Old Child With Growth Impairment: A Case Report. Cureus 2023; doi: 10.7759/cureus.37513
|
3 |
Francesca Penagini, Luisa Lonoce, Luisa Abbattista, Valentina Silvera, Giulia Rendo, Lucia Cococcioni, Dario Dilillo, Valeria Calcaterra, Gian Vincenzo Zuccotti. Dual biological therapy and small molecules in pediatric inflammatory bowel disease. Pharmacological Research 2023; 196: 106935 doi: 10.1016/j.phrs.2023.106935
|
4 |
Kelly Barnhill, Kelly Barnhill, Alan Gutierrez, Alan Gutierrez, Amy Potts, Amy Potts, Morgan Devlin, Wendy Richardson, Laura Hewitson, Ayse Yesim Gocmen. Implementation of an Elemental Diet in Five Children Diagnosed with Autism Spectrum Disorder Presenting with Gastrointestinal Disease: A Brief Report. International Journal of Nutrition 2020; 5(2): 1 doi: 10.14302/issn.2379-7835.ijn-20-3181
|
5 |
Steven Levitte, Reza Yarani, Abantika Ganguly, Lynne Martin, John Gubatan, Helen R. Nadel, Benjamin Franc, Roberto Gugig, Ali Syed, Alka Goyal, K. T. Park, Avnesh S. Thakor. Case Series of Precision Delivery of Methylprednisolone in Pediatric Inflammatory Bowel Disease: Feasibility, Clinical Outcomes, and Identification of a Vasculitic Transcriptional Program. Journal of Clinical Medicine 2023; 12(6): 2386 doi: 10.3390/jcm12062386
|
6 |
Yichen Wang, Chun-Wei Pan, Yuting Huang, Xin Zheng, Si Li, Mingyue He, Jana G Hashash, Francis A Farraye, Adam C Ehrlich. Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae093
|
7 |
Changhee Ha, Eun Sil Kim, Yiyoung Kwon, Yon Ho Choe, Mi Jin Kim, Soo-Youn Lee. <p>The Identification of a Novel Thiopurine S-Methyltransferase Allele, <em>TPMT*45</em>, in Korean Patient with Crohn’s Disease</p>. Pharmacogenomics and Personalized Medicine 2020; : 665 doi: 10.2147/PGPM.S279446
|
8 |
Toshio Arai, Fernando Lopes, Adam Shute, Arthur Wang, Derek M. McKay. Young mice expel the tapeworm Hymenolepis diminuta and are protected from colitis by triggering a memory response with worm antigen. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 314(4): G461 doi: 10.1152/ajpgi.00295.2017
|
9 |
Sunghyun An, Homin Huh, Jae Sung Ko, Jin Soo Moon, Ky Young Cho. Establishment and Characterization of Patient-Derived Intestinal Organoids from Pediatric Crohn’s Disease Patients. Pediatric Gastroenterology, Hepatology & Nutrition 2024; 27(6): 355 doi: 10.5223/pghn.2024.27.6.355
|
10 |
Ha-Yeon Song, Woo Sik Kim, Jin-Man Kim, Dong-Ho Bak, Jeong Moo Han, Seung-Taik Lim, Eui-Baek Byun. A hydroxyethyl derivative of chrysin exhibits anti-inflammatory activity in dendritic cells and protective effects against dextran sodium salt-induced colitis in mice. International Immunopharmacology 2019; 77: 105958 doi: 10.1016/j.intimp.2019.105958
|
11 |
Juan Cristóbal Gana, Andrea Sepúlveda, Esther Orlanski-Meyer, Luis A Villarroel del Pino, Maria Jose de la Piedra Bustamante, Maria Teresa Olivares Labbe. Tumour necrosis factor-alpha antagonists for treatment of paediatric Crohn’s disease. Cochrane Database of Systematic Reviews 2022; 2022(5) doi: 10.1002/14651858.CD014497
|
12 |
Elizabeth A. Jensen, Jonathan A. Young, Samuel C. Mathes, Edward O. List, Ronan K. Carroll, Jaycie Kuhn, Maria Onusko, John J. Kopchick, Erin R. Murphy, Darlene E. Berryman. Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology. Growth Hormone & IGF Research 2020; : 101333 doi: 10.1016/j.ghir.2020.101333
|
13 |
Amy Johnston, Sabrina Natarajan, Meghan Hayes, Erika MacDonald, Risa Shorr. Accelerated induction regimens of TNF-alpha inhibitors in patients with inflammatory bowel disease: a scoping review protocol. BMJ Open 2018; 8(1): e019909 doi: 10.1136/bmjopen-2017-019909
|
14 |
Teresa Whited, Albrey Berber. A 17-Year-Old Male With Abdominal Pain in Primary Care. The Journal for Nurse Practitioners 2019; 15(10): e201 doi: 10.1016/j.nurpra.2019.04.012
|
15 |
Alexander Oberc, Brian K. Coombes. Convergence of External Crohn’s Disease Risk Factors on Intestinal Bacteria. Frontiers in Immunology 2015; 6 doi: 10.3389/fimmu.2015.00558
|
16 |
Yamini Sharma, Athos Bousvaros, Enju Liu, Julia Bender Stern. Natural history of children with mild Crohn’s disease. World Journal of Gastroenterology 2019; 25(30): 4235-4245 doi: 10.3748/wjg.v25.i30.4235
|
17 |
Sana Syed, Asad Ali, Christopher Duggan. Environmental Enteric Dysfunction in Children. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(1): 6 doi: 10.1097/MPG.0000000000001147
|
18 |
Elizabeth A. Jensen, Jonathan A. Young, Jaycie Kuhn, Maria Onusko, Joshua Busken, Edward O. List, John J. Kopchick, Darlene E. Berryman. Growth hormone alters gross anatomy and morphology of the small and large intestines in age- and sex-dependent manners. Pituitary 2022; 25(1): 116 doi: 10.1007/s11102-021-01179-8
|
19 |
Franziska Roth-Walter, Sonja Berger, Nicole Luckschander-Zeller. Comparative Medicine. 2017; : 47 doi: 10.1007/978-3-319-47007-8_4
|
20 |
Leo Fawaz, Yousif Slim, Peter N. Freswick. Endoscopic Guided Dilations without Intralesional Corticosteroid Injections: Pediatric Crohn’s Patients Case Series. Reports 2024; 7(4): 81 doi: 10.3390/reports7040081
|
21 |
Hala Elzayat, Ghaidaa Mesto, Farah Al-Marzooq. Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases. Nutrients 2023; 15(15): 3377 doi: 10.3390/nu15153377
|
22 |
Linah Wetthasinghe, Hien Fuh Ng, Kee Seang Chew, Way Seah Lee. Effect of exclusive enteral nutrition on gut microbiota in Malaysian children with Crohn’s disease. IOP Conference Series: Earth and Environmental Science 2024; 1408(1): 012003 doi: 10.1088/1755-1315/1408/1/012003
|
23 |
Csaba Orbán, Dolóresz Szabó, Anna Bajnok, Barna Vásárhelyi, Tivadar Tulassay, András Arató, Gábor Veres, Gergely Toldi. Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns. Oncotarget 2016; 7(29): 44966 doi: 10.18632/oncotarget.10036
|
24 |
Dhiren Patel, Shailender Madani, Shraddha Patel, Lokesh Guglani. Review of pulmonary adverse effects of infliximab therapy in Crohn’s disease. Expert Opinion on Drug Safety 2016; 15(6): 769 doi: 10.1517/14740338.2016.1160053
|
25 |
Leena Amine, Ibtihal S Abdelgadir, Karen Neves, Mamoun Elawad, Amel Hassan, Anthony K Akobeng. Tacrolimus for induction therapy in active Crohn's disease. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013142
|
26 |
Mackenzie L Lauro, Jason M Burch, Catherine Leimkuhler Grimes. The effect of NOD2 on the microbiota in Crohn's disease. Current Opinion in Biotechnology 2016; 40: 97 doi: 10.1016/j.copbio.2016.02.028
|